期刊文献+

维生素E聚乙二醇1000琥珀酸酯在药物制剂中的应用 被引量:6

Application of D-α-tocopheryl polyethylene glycol succinate 1000 in field of pharmaceutical formulations
原文传递
导出
摘要 维生素E聚乙二醇1000琥珀酸酯(TPGS)作为一种重要的药用辅料,在药学领域应用广泛,可用于制备载体前体药物、胶束和固体分散体,修饰脂质体,并作为增溶剂、渗透促进剂、乳化剂、吸收促进剂等应用于制剂研究中。本文对TPGS的理化性质及其在药物制剂中应用的最新进展进行概述,为合理利用TPGS提供参考。 D-α-tocopheryl polyethylene glycol suecinate 1000 (TPGS) is a very useful pharmaceutical excipient in different kinds of preparations. It can be used to prepare carrier- prodrug, micelle and solid dispersion; to modify liposomal; also can be used as solubilizer, penetration enhancer, emulsifier, absorption enhancer. In this article, the physiochemical property and the recent development of TPGS in pharmaceutical preparation was classified and summarized in order to guide the correct use.
作者 庞鑫 翟光喜
机构地区 山东大学药学院
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2014年第4期247-251,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 维生素E聚乙二醇1000琥珀酸酯 药用制剂 辅料 表面活性剂 D-α-tocopheryl polyethylene glycol succinate 1000 pharmaceutical preparations excipients surface-active agents
  • 相关文献

参考文献34

  • 1MU L, FENG SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol) [J]. J Control Release, 2002, 80 ( 1-3 ) : 129-144.
  • 2DINTAMAN JM, SILVERMAN JA. Inhibition of P-glyco-protein by D - c - toeopheryl polyethylene glycol 1000 succinate (TPGS) [J]. Pharm Res, 1999, 16(10): 1550-1556.
  • 3CAO N, FENG SS. Doxorubicin conjugated to D- alpha- tocopheryl polyethylene glycol 1000 suceinate (TPGS) : conjugation chemistry, characterization, in vitro and in vivo evaluation[J]. Biomaterials, 2008, 29(28): 3856-3865.
  • 4ANBHARASI V, CAO N, FENG SS. Doxorubicin conjugated to D-alpha-toeopheryl polyethylene glycol sueeinate and folic acid as a prodrug for targeted chemotherapy[J]. J Biomed Mater Res A, 2010, 94(3): 730-743.
  • 5MI Y, ZHAO J, FENG SS. Vitamin E TPGS prodrug micelles for hydrophilie drug delivery with neuroproteetive effects[J]. Int J Pharm, 2012, 438(1-2): 98-106.
  • 6SADOQI M, LAU- CAM CA, WU SH. Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometry[J]. J Colloid Interface Sci, 2009, 333 (2) : 585-589.
  • 7XU H, ABE H, NAITO M, et all. Efficient dispersing and shortening of super- growth carbon nanotubes by ultrasonic treatment with ceramic balls and surfactants [J]. Adv Powder Technol, 2010, 21(5): 551-555.
  • 8YAN A, yon dem BUSSCHE A, KANE AB, et al. Toeopheryl polyethylene glycol suecinate as a safe, antioxidant surfaetant for processing carbon nanotubes and fullerenes [J]. Carbon N Y,2007, 45(13): 2463-2470.
  • 9CHANDRASEKHARAN P, MAITY D, YONG CX, et al. Vitamin E (D-alpha-tocopheryl-co-poly (ethylene glycol) 1000 succinate) micelles superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI[J]. Biomaterials, 2011, 32 (24) : 5663-5672.
  • 10SAXENA V, HUSSAIN MD. Poloxamer 407,q'PGS mixed mieelles for delivery of gambogic acid to breast and multidrug- resistant cancer[J]. Int J Nanomedieine, 2012, 7 : 713-721.

二级参考文献10

  • 1查瑞涛,贺晓婷,杜田,袁直.肝靶向甘草次酸修饰的壳聚糖纳米粒子的合成和表征[J].高等学校化学学报,2007,28(6):1098-1100. 被引量:16
  • 2TianQ., ZhangC. N., WangX. H., WangW., HuangW., ChaR. T., WangC. H., YuanZ., Liu M., WanH. Y., TangH.. Biomaterials[ J] , 2010, 31( 17 ) : 4748-4756.
  • 3Zhao t7. , Lin Y., Yung L.. Int. J. Pharos. [J], 2008, 339(1/2) : 256-268.
  • 4Avgoustakis K., Beletsi A., Panagi Z., Klepetsanis P., Karydas A. G., Ithakissios D. S.. J. Control. Release[J], 2002, 79(1-3): 123-135.
  • 5YangJ., ChoE. J., SeoS., LeeJ. W., YoonH. G., SuhJ. S., HuhYM., HaamS.. J. Biomed. Mater. Res.[J],2008,84A ( 1 ) : 273-280.
  • 6ZhangC. N., WangW., WangC. H.,TianQ., HuangW., YuanZ., ChenX. S.. Sci. China, Ser. B[J],2009,52(9): 1382- 1387.
  • 7Tosi G. , Rivasi F. , Gostantino L. , Vandelli M. A.. Biomaterials[ J], 2005, 26(19) : 4189-4195.
  • 8Negishi M. , Irie A. , Nagata N. , Nagata N. , lchikawa A.. Biochim. Biophys. Acta[J] , 1991, 1066( 1 ) : 77-82.
  • 9ZHARui-Tao(查瑞涛) DUTian(杜田) YUANZhi(袁直).高等学校化学学报,2006,27(2):885-887.
  • 10毛声俊,侯世祥,金辉,张良珂,蒋彬.肝细胞靶向甘草次酸表面修饰脂质体的制备[J].中国中药杂志,2003,28(4):328-331. 被引量:37

共引文献18

同被引文献62

  • 1许汉林,张念,程光明,郭妮.姜黄素脂质体制备工艺的研究[J].湖北中医学院学报,2009,11(1):36-39. 被引量:5
  • 2蔡启祥,张建祥,朱康杰.基于聚酸酐的生物黏附性载药高分子[J].浙江大学学报(工学版),2004,38(9):1222-1226. 被引量:5
  • 3许汉林,孙芸,邵继征,熊利容,张念,黄成刚.姜黄素脂质体在大鼠体内药代动力学研究[J].湖北中医学院学报,2007,9(1):42-43. 被引量:27
  • 4Chen H,Wu J,Sun M,et al.N-trimethyl chitosan chloridecoated liposomes for the oral delivery of curcumin[J].J Liposome Res,2012,22(2):100-109.
  • 5Dahan A,West B T,Amidon G L.Segmental-dependent membrane permeability along the intestine following oral drug administration:Evaluation of a triple single-pass intestinal perfusion(TSPIP)approach in the rat[J].Eur J Pharm Sci,2009,36(2-3):320-329.
  • 6Aisner J. Overview of the changing paradigm in cancer treatment : oral chemotherapy [ J ]. Am J Health-Syst Pharm, 2007,64 ( 9 ) : S4-7.
  • 7Sareen S, Mathew G, Joseph L. Improvement insolubility of poor water-solubledrugs by solid dispersion[ J]. lnt J Pharm Investig, 2012,2 ( 1 ) :12-17.
  • 8Owen SC, Chan DPY, Shoichet MS. Polymeric mieelle stability [ J]. Nano Today,2012,7( 1 ) :53-65.
  • 9Kedar U, Phutane P, Shidhaye S, et al. Advances in polymeric mi- celles for drug delivery and tumor targeting [ J ]. Nanomedicine, 2010,6(6) :714-729. A.
  • 10ttia ABE, Ong ZY, Hedrick JL, et al. Mixed micelles self-assem- bly from block copolymers for drug delivery [ J ]. Curr Opin Colliod In,2011,16(3) :182-194.

引证文献6

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部